GlaxoSmithKline board rejects ACDIMA’s takeover offer for Egypt assets
GlaxoSmithKline on Sunday said its board rejected a request from the Arab Company for Drug Industries & Medical…
Browsing Tag
GlaxoSmithKline
Hikma, GlaxoSmithKline cease talks over potential deal to buy Egypt, Tunisia assets
GlaxoSmithKline said on Thursday that its majority shareholder Glaxo Group Limited and Hikma Pharmaceuticals have…
Rameda withdraws offer to acquire GlaxoSmithKline Egypt stake
Egypt’s Rameda Pharmaceutical said in a bourse filling on Tuesday it had withdrawn its proposal to acquire…
GlaxoSmithKline in talks with Hikma to sell Egypt stake, rules out talks with Rameda
GlaxoSmithKline will focus its efforts and resources on discussing the sale of its stake in Egypt with Hikma…
Rameda joins race to buy GlaxoSmithKline assets in Egypt
Egypt's Rameda Pharmaceutical said on Tuesday it had submitted a non-binding letter of intent to purchase…
Acdima expressed interest in buying majority stake in GlaxoSmithKline Egypt
Arab Company for Drug Industries and Medical Appliances (Acdima – Egypt) expressed an interest in acquiring…
GlaxoSmithKline allows Hikma Pharmaceuticals due diligence on Egypt, Tunisia assets
GlaxoSmithKline said on Wednesday its board of directors has allowed Hikma Pharmaceuticals, which is interested in…
Hikma mulls buying GlaxoSmithKline assets in Egypt and Tunisia
Hikma Pharmaceuticals announced on Tuesday plans to buy GlaxoSmithKline’s stake in some assets including the…
Sanofi coronavirus vaccine will be priced below €10 – France chief
A coronavirus vaccine being developed by Sanofi in partnership with Britain’s GlaxoSmithKline is expected to be…
Sanofi ready to produce over 600 million coronavirus vaccine doses if proven successful
French drugmaker Sanofi is ready to produce up to 600 million doses of its coronavirus vaccine next year if its…
Sanofi and GlaxoSmithKline reach unprecedented partnership to develop coronavirus vaccine
The European pharmaceutical giants, GlaxoSmithKline and Sanofi have entered on Tuesday an unprecedented partnership…
Kenya is now the third African country to introduce malaria vaccine
Kenya has on Friday started adding a malaria vaccine to its routine immunization schedule for babies and toddlers,…
UK firms bullish on Egypt, eyeing more investment
A number of UK-based firms have shown plans to step up their investments in Egypt, which currently amount to $43…
British BP to invest $13b in Egypt before 2020
British oil company BP Global plans to invest US$13 billion in the Egyptian market before 2020, the UK…
GSK-Egypt losses shrink by 6% in Q2-2016
Glaxo Smith Kline SAE (GSK) posted net losses of 72.91 million Egyptian Pounds in the first quarter of the fiscal…
GlaxoSmithKline and Alphabet establish $715 million bioelectronics firm
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases by…
GlaxoSmithKline pumps 400 mln Egyptian pounds into Egypt until 2017
Drugmaker GlaxoSmithKline plans to pump investments worth 400 million Egyptian pounds ($45 million) into Egypt…
British investments in Egypt worth $26million- GAFI
The economic ties between Egypt and UK are in continuous growth year after year since Britain is the largest…
Ebola Vaccine from Glaxo Passes Early Trials
A possible Ebola vaccine under development by GlaxoSmithKline PLC GSK, +0.12% GSK, +0.52% and various U.S.…
Pfizer Steps up $100 Billion Bid for Astrazeneca
Pfizer Inc. confirmed Monday that it made a renewed approach to AstraZeneca PLC regarding a takeover valued at…
FTSE Rises for Second Day As Miners Push Higher
After rising for two straight weeks, U.K. stocks continued to advance on Monday, with resource firms driving the…
Europe Stocks Up; Ryanair, Weir Sink on Warnings
European stock markets opened higher on Monday, with heavyweight banks, chemical stocks and pharmaceuticals leading…
Europe Shares Off Ahead of Fed Announcement, Banks Up
European stock markets erased some of the prior day’s sharp gains on Wednesday, while investors awaited a policy…